When choosing a pump, take the time you need to make a good choice. You will depend on this pump for 4 to 5 years, so discuss different pumps and pump options with your doctor and health care team to select the features that will be most helpful. Be sure to take a look at our Pump Comparison Page to help with your pump choice.
Diabetes technology section
A pump offers convenience, more consistent insulin action from day to day, easier problem solving, easier tracking of insulin use, less hypoglycemia, less risk of hypoglycemia unawareness, and fewer morning and post-meal highs. These conveniences come from specific features that are standard in most pumps. Training is required to benefit from all the pump features listed below.
At the 72nd Scientific Sessions of the American Diabetes Association, Tandem announced that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on Monday, June 11, 2012 starting at 6:00am. The product will begin shipping in August 2012.
Full press release is below.
Due to complaints about glucose meter inaccuracy, the Food and Drug Administration (FDA) is currently developing a new standard for glucose meter accuracy.
Insulet and Johnson & Johnson announced an agreement to incorporate the OneTouch technology into the Omnipod's remote controller. The next Omnipod will have a built in blood glucose meter in the PDM, allowing you to carry one less device. Insulet already has a deal with Abbott Diabetes Care to include their Freestyle technology in their new PDM but the deal isn't exclusive. Upon release, Insulet could decide to have a separate device for each blood glucose meter technology or switch to Lifescan exclusively after the Abbott deal expires in 2013.
The Food and Drug Administration has reached an agreement with medical device makers that should increase the speed in which they evaluate new devices. The much maligned approval process has long been thought to be slow and unpredictable. For the last decade, the FDA has accepted company payments to supplement it's budget and create a smoother process, totaling $295 million in the last agreement. This new deal raises that budget to $595 million over the next five years, allowing the FDA to hire 200 new scientist.